Moors & Cabot’s NeoGenomics NEO Stock Holding History

Moors & Cabot’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$230K	Buy	15,750 +2,750	+21%	+$26.5K	0.01%	854
2026 Q1	$96.5K	Sell	13,000 -2,500	-16%	-$26.3K	﹤0.01%	902
2025 Q4	$182K	Buy	15,500 +1,750	+13%	+$18.9K	0.01%	859
2025 Q3	$106K	Buy	13,750 +1,750	+15%	+$12.3K	﹤0.01%	880
2025 Q2	$87.7K	Buy	12,000 +2,000	+20%	+$16.1K	﹤0.01%	859
2025 Q1	$94.9K	Buy	+10,000	New	+$125K	﹤0.01%	840

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Moors & Cabot's NEO Position: Q2 2026 in Review

Moors & Cabot increased its NeoGenomics (NEO) stake by 21% in Q2 2026, buying an estimated $26.5K and bringing the position to 15,750 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #854.

Moors & Cabot first reported a position in NEO in Q1 2025 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Moors & Cabot held 15,750 shares of NeoGenomics worth $230K as of Q2 2026.
Moors & Cabot bought 2,750 NeoGenomics shares in Q2 2026, an estimated $26.5K.
NeoGenomics made up 0.01% of Moors & Cabot's portfolio in Q2 2026, its #854 holding.
Moors & Cabot first reported a position in NeoGenomics in Q1 2025 and has held it in 6 quarters since.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.